Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Parents Exposed to Aggressive Baby Formula Marketing, WHO Report Finds Baby formula marketing has violated international standards and attempted to influence which products health care workers recommended to new parents March 14, 2022 Irvin Jackson Add Your Comments A recent report by international health experts warns that parents and expecting mothers are often bombarded with aggressive infant formula advertising, even when formula feeding may not be the best option for the child. The World Health Organization (WHO) released a report on infant formula marketing (PDF) on February 22, revealing that more than half of parents and pregnant women are targeted by advertising in a way that “compromises child nutrition” and violates some international standards and commitments. The findings come amid increasing concerns about marketing efforts by the makers of Similac and Enfamil, which some critics have indicated were a direct response to moves in recent years by health officials to promote breast feeding. Hundreds of families nationwide are now pursuing Similac lawsuits and Enfamil lawsuits after premature babies developed a devastating gastrointestinal condition, known as necrotizing enterocolitis (NEC), alleging that the manufacturers suppressed information about the increased risk associated with use of the cow’s milk formula and fortifier products, compared to breast milk. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to WHO investigators, the $55 billion formula industry has employed unregulated and invasive online advertising, sponsored networks and helplines, and gave out promotions and free gifts to influence parents and health workers. Many of those advertisements and outreaches were misleading, scientifically inaccurate or unsubstantiated, and violated the International Code of Marketing of Breast-milk substitutes, which was passed by the World Health Assembly in 1981 to prevent just such tactics, WHO said. “This report shows very clearly that formula milk marketing remains unacceptably pervasive, misleading and aggressive,” Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, said in a press release. “Regulations on exploitative marketing must be urgently adopted and enforced to protect children’s health.” The WHO survey collected data from 8,500 parents and pregnant women, as well as 300 health workers from several countries, including Bangladesh, China, Mexico, Morocco, Nigeria, South Africa, the United Kingdom and Vietnam. According to the report, 84% of women in the U.K, 92% of women in Vietnam and 97% of women in China say the were subjected to formula marketing which increased the likelihood that they would choose formula feeding. The report also indicates a large number of health care workers from around the world say they were approached by the formula industry, which tried to influence their recommendations to new parents with promotional gifts, free samples, research funding, paying for trips to meetings, events and conferences, and even offering some commissions on sales, with more than a third of women surveyed saying a health worker had recommended they use a specific brand of infant formula. WHO is encouraging nations to pass and enforce laws preventing the promotion of formula milk, investing in policies that support breastfeeding, granting paid parental leave, requesting the industry publicly commit to complying with international codes and banning health workers from being sponsored by companies that market food to infants and young children. NEC Formula Lawsuits Necrotizing enterocolitis is one of the more severe risks associated with cow’s milk-based infant formula products, such as Enfamil and Similac, which occurs when the wall of the intestine are invaded by bacteria, leading to destruction of the bowel and often requiring emergency surgery or death. The condition poses a particularly high risk for premature and low-birth weight infants, where studies have shown that baby formula causes NEC at alarming rates, compared to breast feeding. However, Similac and Enfamil have each introduced and marketed versions of their formula in recent years that are specifically intended for premature babies, without providing warnings about the NEC risk. In a study published in November, Canadian researchers warned that preterm and low birth weight infants given cow’s milk-based formula were three times as likely to be transferred to a neonatal intensive care unit (NICU) for suspected NEC than those given donor milk. Similar findings were published in October in the medical journal Nutrients, which found that breast milk was the “gold standard” for nutritional support during infancy, with antimicrobial and bioactive factors which helped prevent NEC. Abbott Laboratories and Mead Johnson face a growing number of NEC formula lawsuits being filed by parents, each raising similar factual allegations that marketing by the manufacturers caused these formulas to displace breast milk that infants would have otherwise received, robbing them of a primary defense against NEC. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Breast Feeding, Enfamil, False Advertising, Infant Formula, NEC, Similac, World Health Organization Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 4 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 5 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 6 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025
Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 4 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 5 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 6 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)